Advertisement
Screener

ENTRADA THERAPEUTICS, INC. (TRDA) ROA

ENTRADA THERAPEUTICS, INC. (TRDA) ROA

  • 2026-06-30: ROA -55.47%.
  • 2026-03-31: ROA -49.51%.
  • 2025-12-31: ROA -38.09%.
  • 2025-09-30: ROA -25.06%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-55.47%
2026-03-31-49.51%
2025-12-31-38.09%
2025-09-30-25.06%
2025-06-30-16.34%
2025-03-315.09%
2024-12-3112.47%
2024-09-309.91%
2024-06-3017.95%
2024-03-314.60%
2023-12-31-1.42%
2023-09-30-4.49%
2023-06-30-16.67%
2023-03-31-16.74%
2022-12-31-37.54%
2022-09-30-32.22%
2022-06-30-26.27%
2022-03-31-20.35%
2021-12-31-16.73%
2021-09-30-31.26%
2020-12-31-60.93%

Annual ROA

DateROA
2025-12-31-38.09%
2024-12-3112.47%
2023-12-31-1.42%
2022-12-31-37.54%
2021-12-31-16.73%
2020-12-31-60.93%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
MACROGENICS INC (MGNX)United States$0.242B-20.11
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Akebia Therapeutics, Inc. (AKBA)United States$0.255B-10.35
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55